Validus Holdings, Ltd. (NYSE:VR) Director Michael E.A. Carpenter sold 10,000 shares of Validus stock in a transaction that occurred on Monday, March 12th. The stock was sold at an average price of $67.70, for a total value of $677,000.00. The sale was disclosed in a legal filing with the SEC, which is available at the SEC website.
Shares of NYSE VR traded down $0.12 during trading on Friday, reaching $67.47. The stock had a trading volume of 757,964 shares, compared to its average volume of 644,000. Validus Holdings, Ltd. has a fifty-two week low of $41.15 and a fifty-two week high of $67.79. The company has a current ratio of 0.90, a quick ratio of 0.90 and a debt-to-equity ratio of 0.54. The stock has a market capitalization of $5,352.13, a PE ratio of -63.06, a PEG ratio of 1.78 and a beta of 0.99.
Validus (NYSE:VR) last issued its quarterly earnings data on Thursday, February 1st. The insurance provider reported $0.05 earnings per share for the quarter, missing the Zacks’ consensus estimate of $1.05 by ($1.00). Validus had a negative net margin of 1.70% and a negative return on equity of 1.85%. The firm had revenue of $346.88 million during the quarter, compared to analyst estimates of $352.00 million. During the same period in the previous year, the firm posted $0.80 earnings per share. The company’s quarterly revenue was up 16.1% compared to the same quarter last year. equities analysts predict that Validus Holdings, Ltd. will post 4.22 earnings per share for the current year.
The business also recently announced a quarterly dividend, which was paid on Thursday, March 29th. Investors of record on Thursday, March 15th were paid a dividend of $0.38 per share. The ex-dividend date of this dividend was Wednesday, March 14th. This represents a $1.52 annualized dividend and a yield of 2.25%. Validus’s payout ratio is -142.06%.
A number of institutional investors and hedge funds have recently added to or reduced their stakes in the stock. The Manufacturers Life Insurance Company grew its stake in Validus by 10.1% during the 2nd quarter. The Manufacturers Life Insurance Company now owns 2,382 shares of the insurance provider’s stock worth $124,000 after purchasing an additional 219 shares in the last quarter. Monarch Partners Asset Management LLC grew its stake in Validus by 1.4% during the 4th quarter. Monarch Partners Asset Management LLC now owns 58,514 shares of the insurance provider’s stock worth $2,745,000 after purchasing an additional 800 shares in the last quarter. Amalgamated Bank grew its stake in Validus by 6.1% during the 4th quarter. Amalgamated Bank now owns 14,785 shares of the insurance provider’s stock worth $694,000 after purchasing an additional 848 shares in the last quarter. California State Teachers Retirement System grew its stake in Validus by 0.7% during the 4th quarter. California State Teachers Retirement System now owns 132,121 shares of the insurance provider’s stock worth $6,199,000 after purchasing an additional 919 shares in the last quarter. Finally, Laurel Wealth Advisors Inc. grew its stake in Validus by 13.2% during the 4th quarter. Laurel Wealth Advisors Inc. now owns 10,671 shares of the insurance provider’s stock worth $500,000 after purchasing an additional 1,241 shares in the last quarter. 98.99% of the stock is owned by hedge funds and other institutional investors.
Several equities research analysts have issued reports on the company. Buckingham Research cut Validus from a “buy” rating to a “neutral” rating in a research note on Tuesday, February 13th. JMP Securities cut Validus from an “outperform” rating to a “market perform” rating in a research note on Tuesday, January 30th. Keefe, Bruyette & Woods cut Validus from an “outperform” rating to a “market perform” rating in a research note on Monday, January 22nd. Zacks Investment Research cut Validus from a “hold” rating to a “sell” rating in a research note on Saturday, January 13th. Finally, Barclays reissued a “hold” rating and set a $50.00 target price on shares of Validus in a research note on Tuesday, January 9th. Two research analysts have rated the stock with a sell rating, seven have assigned a hold rating and one has given a buy rating to the company’s stock. The company presently has an average rating of “Hold” and an average price target of $52.80.
TRADEMARK VIOLATION NOTICE: This story was first published by Dispatch Tribunal and is the property of of Dispatch Tribunal. If you are accessing this story on another publication, it was stolen and reposted in violation of international copyright & trademark laws. The correct version of this story can be viewed at https://www.dispatchtribunal.com/2018/04/08/validus-holdings-ltd-vr-director-sells-677000-00-in-stock.html.
Validus Company Profile
Validus Holdings, Ltd. provides reinsurance coverage, insurance coverage, and insurance linked securities management services worldwide. It operates through three segments: Reinsurance, Insurance, and Asset Management. The Reinsurance segment underwrites property reinsurance products on a catastrophe excess of loss, per risk excess of loss and proportional basis; and aerospace and aviation, agriculture, composite, marine, technical lines, terrorism, trade credit, workers' compensation, and other specialty lines, as well as casualty and financial lines.
Receive News & Ratings for Validus Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Validus and related companies with MarketBeat.com's FREE daily email newsletter.